Randomised phase 3 open-label trial of first-line treatment with gemcitabine in association with docetaxel or paclitaxel in women with metastatic breast cancer: a comparison of different schedules and treatments

Peer Review reports

Original Submission
28 Nov 2012	Submitted	Original manuscript
5 Jan 2013	Reviewed	Reviewer Report - Manuela Rabaglio
6 Jan 2013	Reviewed	Reviewer Report - Khalil Zaman
13 Feb 2013	Author responded	Author comments - Paolo Marchi
Resubmission - Version 2
13 Feb 2013	Submitted	Manuscript version 2
28 Feb 2013	Reviewed	Reviewer Report - Manuela Rabaglio
3 Mar 2013	Reviewed	Reviewer Report - Khalil Zaman
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
18 Mar 2013	Editorially accepted
28 Mar 2013	Article published	10.1186/1471-2407-13-164

Back to article page